Huntington Bancshares Inc Maintains Dividend Levels

By Tamara Parker • Saturday, October 18 15:37 • Permanent Link

Huntington Bancshares Incorporated has declared a quarterly cash dividend on its common stock (NASDAQ: HBAN) of $0.155 per common share, maintaining the same level as the prior quarter. The common stock cash dividend is payable on January 2, 2026, to shareholders of record on December 18, 2025.

In addition to the common stock dividend, the board also declared quarterly cash dividends on six series of its preferred stock:

Floating Rate Series B Non-Cumulative Perpetual Preferred Stock (CUSIP#: 446150500): $17.16537324 per share (equivalent to $0.429134300 per depositary receipt share).
5.625% Series F Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock (CUSIP#: 446150AT1): $1,406.25 per share (equivalent to $14.0625 per depositary share).
4.450% Series G Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock (CUSIP#: 446150AV6): $1,112.50 per share (equivalent to $11.1250 per depositary share).
4.5% Series H Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock (NASDAQ: HBANP): $11.25 per share (equivalent to $0.28125 per depositary share).
6.875% Series J Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock (NASDAQ: HBANL): $17.19 per share (equivalent to $0.42975 per depositary share).
6.25% Series K Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock (CUSIP#: 446150BG8): $2,152.78 per share (equivalent to $21.528 per depositary share).

All six preferred stock cash dividends are payable on January 15, 2026, to their respective shareholders of record on January 1, 2026.

Huntington Bancshares Incorporated, a $210 billion asset regional bank holding company headquartered in Columbus, Ohio, operates 972 branches in 13 states, with certain businesses operating in extended geographies. Following these announcements, the company's shares moved -5.18%, and are now trading at a price of $15.37. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.